1FQ1 - Header Asymmetric Unit

HEADER HYDROLASE/TRANSFERASE 01-SEP-00 1FQ1

TITLE CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN TITLE 2 COMPLEX WITH PHOSPHO-CDK2

COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE INHIBITOR 3; COMPND 3 CHAIN: A; COMPND 4 EC: 3.1.3.48; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 9 CHAIN: B; COMPND 10 EC: 2.7.11.22; COMPND 11 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PGEX-6P; SOURCE 8 OTHER_DETAILS: HOMO SAPIENS; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_VECTOR: PGEX-6P; SOURCE 16 OTHER_DETAILS: HOMO SAPIENS

KEYWDS PHOSPHO-PROTEIN/PROTEIN COMPLEX, HYDROLASE/TRANSFERASE KEYWDS 2 COMPLEX

EXPDTA X-RAY DIFFRACTION

AUTHOR H.SONG,N.HANLON,N.R.BROWN,M.E.M.NOBLE,L.N.JOHNSON,D.BARFORD

REVDAT 4 24-FEB-09 1FQ1 1 VERSN REVDAT 3 26-AUG-08 1FQ1 1 COMPND REVDAT 2 01-APR-03 1FQ1 1 JRNL REVDAT 1 09-MAY-01 1FQ1 0

JRNL AUTH H.SONG,N.HANLON,N.R.BROWN,M.E.NOBLE,L.N.JOHNSON, JRNL AUTH 2 D.BARFORD JRNL TITL PHOSPHOPROTEIN-PROTEIN INTERACTIONS REVEALED BY JRNL TITL 2 THE CRYSTAL STRUCTURE OF KINASE-ASSOCIATED JRNL TITL 3 PHOSPHATASE IN COMPLEX WITH PHOSPHOCDK2. JRNL REF MOL.CELL V. 7 615 2001 JRNL REFN ISSN 1097-2765 JRNL PMID 11463386 JRNL DOI 10.1016/S1097-2765(01)00208-8

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.Y.C.POON,T.HUNTER REMARK 1 TITL DEPHOSPHORYLATION OF CDK2 THR160 BY THE CYCLIN REMARK 1 TITL 2 DEPENDENT KINASE-INTERACTING PHOSPHATASE KAP IN REMARK 1 TITL 3 THE ABSENCE OF CYCLIN REMARK 1 REF SCIENCE V. 270 90 1995 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.GYRURIS,E.GOLEMIS,H.CHERTKOV,R.BRENT REMARK 1 TITL CDI1, A HUMAN G1 AND S PHASE PROTEIN PHOSPHATASE REMARK 1 TITL 2 THAT ASSOCIATES WITH CDK2 REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 75 791 1993 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(93)90498-F REMARK 1 REFERENCE 3 REMARK 1 AUTH J.W.HARPER,G.R.ADAMI,N.WEI,K.KEYOMARSI,S.J.ELLEDGE REMARK 1 TITL THE P21CDK-INTERACTING PROTEIN CIP1 IS A POTENT REMARK 1 TITL 2 INHIBITOR OF G1 CYCLIN-DEPENDENT KINASES REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 75 805 1993 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(93)90499-G

REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 13940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.313 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 702 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3822 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 95.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1FQ1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-SEP-00. REMARK 100 THE RCSB ID CODE IS RCSB011804.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17091 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000,KCL, MGACETATE,NA REMARK 280 CACODYLATE , PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.86667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 21.93333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 21.93333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 43.86667 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 PRO A 3 REMARK 465 PRO A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 ILE A 7 REMARK 465 GLN A 8 REMARK 465 THR A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 PHE A 12 REMARK 465 ASP A 13 REMARK 465 SER A 14 REMARK 465 SER A 15 REMARK 465 ASP A 16 REMARK 465 GLU A 17 REMARK 465 GLU A 18 REMARK 465 PRO A 19 REMARK 465 ILE A 20 REMARK 465 ASP A 204 REMARK 465 SER A 205 REMARK 465 GLN A 206 REMARK 465 SER A 207 REMARK 465 ARG A 208 REMARK 465 SER A 209 REMARK 465 VAL A 210 REMARK 465 SER A 211 REMARK 465 ARG A 212 REMARK 465 ARG B 297 REMARK 465 LEU B 298

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 46 N ALA B 48 1.94 REMARK 500 OD1 ASP B 206 OD2 ASP B 210 2.09 REMARK 500 O VAL B 230 N SER B 232 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE B 35 C ARG B 36 N -0.149 REMARK 500 THR B 47 C ALA B 48 N -0.193 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE B 35 CA - C - N ANGL. DEV. = 21.3 DEGREES REMARK 500 ILE B 35 O - C - N ANGL. DEV. = -24.6 DEGREES REMARK 500 ALA B 48 C - N - CA ANGL. DEV. = -27.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 22 -169.16 33.07 REMARK 500 GLU A 23 -38.83 9.70 REMARK 500 ARG A 36 7.55 -67.36 REMARK 500 LYS A 54 92.81 17.44 REMARK 500 VAL A 60 -79.49 -45.71 REMARK 500 GLN A 73 -72.23 -91.71 REMARK 500 CYS A 79 -150.08 -87.39 REMARK 500 VAL A 89 47.35 -144.65 REMARK 500 GLN A 98 45.10 -85.70 REMARK 500 GLU A 124 -76.05 -57.81 REMARK 500 ASN A 132 40.98 -98.20 REMARK 500 TYR A 133 38.16 33.05 REMARK 500 SER A 140 -131.86 -134.43 REMARK 500 TYR A 141 -72.19 -90.67 REMARK 500 LEU A 144 -6.51 -172.09 REMARK 500 SER A 177 3.86 -69.56 REMARK 500 ALA A 179 -113.67 -27.98 REMARK 500 THR A 182 172.19 -58.93 REMARK 500 ALA A 198 -13.23 -47.66 REMARK 500 HIS A 199 41.38 -89.99 REMARK 500 SER A 201 70.48 -58.03 REMARK 500 GLU B 2 116.80 54.23 REMARK 500 ASN B 3 87.32 -49.10 REMARK 500 GLU B 12 79.58 -176.67 REMARK 500 THR B 14 98.91 23.03 REMARK 500 TYR B 15 77.14 34.70 REMARK 500 LYS B 24 18.91 -60.55 REMARK 500 LEU B 25 -78.41 -127.42 REMARK 500 GLU B 28 89.81 36.07 REMARK 500 VAL B 29 -154.62 33.31 REMARK 500 VAL B 30 137.63 133.43 REMARK 500 LEU B 32 121.04 -30.92 REMARK 500 LYS B 33 -158.81 -89.44 REMARK 500 LYS B 34 146.67 -179.29 REMARK 500 LEU B 37 -66.94 -120.62 REMARK 500 ASP B 38 10.65 87.32 REMARK 500 THR B 39 172.55 58.62 REMARK 500 VAL B 44 161.88 68.27 REMARK 500 THR B 47 -1.67 -38.59 REMARK 500 ALA B 48 -57.06 -138.64 REMARK 500 SER B 53 -71.96 -60.78 REMARK 500 GLU B 57 -39.14 -38.01 REMARK 500 ASN B 62 47.83 -73.32 REMARK 500 VAL B 64 135.15 -27.07 REMARK 500 THR B 72 130.85 -27.04 REMARK 500 LEU B 83 52.88 -154.45 REMARK 500 HIS B 84 -87.33 56.63 REMARK 500 ASP B 92 -74.80 -53.64 REMARK 500 ALA B 93 55.80 -57.56 REMARK 500 SER B 94 -11.53 -179.28 REMARK 500 ALA B 95 1.59 -62.87 REMARK 500 LEU B 101 -32.95 -37.82 REMARK 500 GLN B 113 -82.33 -57.20 REMARK 500 ARG B 126 -25.61 80.93 REMARK 500 LYS B 129 141.27 -170.39 REMARK 500 PRO B 130 -55.14 -28.65 REMARK 500 ASP B 145 67.63 37.68 REMARK 500 PHE B 152 151.04 -27.30 REMARK 500 LEU B 166 -12.02 69.72 REMARK 500 TYR B 179 159.61 46.82 REMARK 500 SER B 181 -167.03 -113.60 REMARK 500 CYS B 191 -71.05 -44.64 REMARK 500 ILE B 192 -36.29 -37.57 REMARK 500 VAL B 197 -89.09 -69.35 REMARK 500 THR B 198 -6.36 -54.85 REMARK 500 ARG B 199 -33.05 74.95 REMARK 500 LEU B 212 -87.98 -50.93 REMARK 500 PHE B 213 -41.53 -25.61 REMARK 500 VAL B 225 -71.44 -48.65 REMARK 500 THR B 231 17.76 -49.84 REMARK 500 PRO B 234 -66.96 -14.20 REMARK 500 ASP B 235 44.13 -99.47 REMARK 500 PRO B 241 177.37 -56.94 REMARK 500 ARG B 245 137.58 -28.14 REMARK 500 ASP B 247 133.43 -10.33 REMARK 500 PHE B 248 -23.56 -38.79 REMARK 500 SER B 249 -17.86 -47.62 REMARK 500 VAL B 252 56.97 -144.71 REMARK 500 PRO B 254 -4.62 -52.94 REMARK 500 LEU B 255 -166.58 -100.68 REMARK 500 ASP B 256 -127.94 -129.32 REMARK 500 LEU B 281 -3.81 -46.07 REMARK 500 ALA B 282 -75.06 -93.18 REMARK 500 HIS B 283 129.50 5.64 REMARK 500 GLN B 287 -84.67 -30.95 REMARK 500 PRO B 292 137.02 -37.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ILE B 35 14.99 REMARK 500 THR B 47 -21.96 REMARK 500 REMARK 500 REMARK: NULL

REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 383 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 132 OD1 REMARK 620 2 ATP B 381 O3B 108.8 REMARK 620 3 ATP B 381 O2A 162.5 75.6 REMARK 620 4 ATP B 381 O2G 59.1 49.7 122.4 REMARK 620 5 ASN B 132 ND2 49.8 101.0 113.1 68.8 REMARK 620 6 ATP B 381 O1G 91.8 52.0 103.6 58.8 126.5 REMARK 620 N 1 2 3 4 5

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 383 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 381

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FPZ RELATED DB: PDB

DBREF 1FQ1 A 1 212 UNP Q16667 CDKN3_HUMAN 1 212 DBREF 1FQ1 B 1 298 UNP P24941 CDK2_HUMAN 1 298

SEQADV 1FQ1 SER A 140 UNP Q16667 CYS 140 MUTATION.

SEQRES 1 A 212 MET LYS PRO PRO SER SER ILE GLN THR SER GLU PHE ASP SEQRES 2 A 212 SER SER ASP GLU GLU PRO ILE GLU ASP GLU GLN THR PRO SEQRES 3 A 212 ILE HIS ILE SER TRP LEU SER LEU SER ARG VAL ASN CYS SEQRES 4 A 212 SER GLN PHE LEU GLY LEU CYS ALA LEU PRO GLY CYS LYS SEQRES 5 A 212 PHE LYS ASP VAL ARG ARG ASN VAL GLN LYS ASP THR GLU SEQRES 6 A 212 GLU LEU LYS SER CYS GLY ILE GLN ASP ILE PHE VAL PHE SEQRES 7 A 212 CYS THR ARG GLY GLU LEU SER LYS TYR ARG VAL PRO ASN SEQRES 8 A 212 LEU LEU ASP LEU TYR GLN GLN CYS GLY ILE ILE THR HIS SEQRES 9 A 212 HIS HIS PRO ILE ALA ASP GLY GLY THR PRO ASP ILE ALA SEQRES 10 A 212 SER CYS CYS GLU ILE MET GLU GLU LEU THR THR CYS LEU SEQRES 11 A 212 LYS ASN TYR ARG LYS THR LEU ILE HIS SER TYR GLY GLY SEQRES 12 A 212 LEU GLY ARG SER CYS LEU VAL ALA ALA CYS LEU LEU LEU SEQRES 13 A 212 TYR LEU SER ASP THR ILE SER PRO GLU GLN ALA ILE ASP SEQRES 14 A 212 SER LEU ARG ASP LEU ARG GLY SER GLY ALA ILE GLN THR SEQRES 15 A 212 ILE LYS GLN TYR ASN TYR LEU HIS GLU PHE ARG ASP LYS SEQRES 16 A 212 LEU ALA ALA HIS LEU SER SER ARG ASP SER GLN SER ARG SEQRES 17 A 212 SER VAL SER ARG SEQRES 1 B 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 B 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 B 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 B 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 B 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 B 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 B 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 B 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 B 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 B 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 B 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 B 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 B 298 ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 B 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 B 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 B 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 B 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 B 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 B 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 B 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 B 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 B 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 B 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU

MODRES 1FQ1 TPO B 160 THR PHOSPHOTHREONINE

HET TPO B 160 11 HET MG B 383 1 HET ATP B 381 31

HETNAM TPO PHOSPHOTHREONINE HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE

HETSYN TPO PHOSPHONOTHREONINE

FORMUL 2 TPO C4 H10 N O6 P FORMUL 3 MG MG 2+ FORMUL 4 ATP C10 H16 N5 O13 P3

HELIX 1 1 SER A 35 ASN A 38 5 4 HELIX 2 2 ASN A 59 GLY A 71 1 13 HELIX 3 3 THR A 80 TYR A 87 1 8 HELIX 4 4 ASN A 91 GLN A 98 1 8 HELIX 5 5 ASP A 115 ASN A 132 1 18 HELIX 6 6 GLY A 145 SER A 159 1 15 HELIX 7 7 SER A 163 GLY A 176 1 14 HELIX 8 8 THR A 182 ALA A 198 1 17 HELIX 9 9 PRO B 45 LEU B 58 1 14 HELIX 10 10 LEU B 87 ALA B 93 1 7 HELIX 11 11 PRO B 100 SER B 120 1 21 HELIX 12 12 LYS B 129 GLN B 131 5 3 HELIX 13 13 ASP B 145 ALA B 149 5 5 HELIX 14 14 ALA B 170 LEU B 175 1 6 HELIX 15 15 VAL B 184 ARG B 199 1 16 HELIX 16 16 SER B 207 GLY B 220 1 14 HELIX 17 17 ASP B 247 VAL B 252 1 6 HELIX 18 18 ASP B 258 LEU B 267 1 10 HELIX 19 19 SER B 276 HIS B 283 1 8 HELIX 20 20 PRO B 284 GLN B 287 5 4

SHEET 1 A 5 SER A 30 SER A 33 0 SHEET 2 A 5 PHE A 42 LEU A 45 -1 O LEU A 43 N LEU A 32 SHEET 3 A 5 THR A 136 HIS A 139 1 O THR A 136 N GLY A 44 SHEET 4 A 5 ASP A 74 VAL A 77 1 O ASP A 74 N LEU A 137 SHEET 5 A 5 ILE A 102 HIS A 105 1 O ILE A 102 N ILE A 75 SHEET 1 B 2 LYS B 9 GLY B 11 0 SHEET 2 B 2 VAL B 18 TYR B 19 -1 N VAL B 18 O GLY B 11 SHEET 1 C 3 GLN B 85 ASP B 86 0 SHEET 2 C 3 LEU B 133 ILE B 135 -1 N ILE B 135 O GLN B 85 SHEET 3 C 3 ILE B 141 LEU B 143 -1 N LYS B 142 O LEU B 134 SHEET 1 D 2 VAL B 123 LEU B 124 0 SHEET 2 D 2 ARG B 150 ALA B 151 -1 O ARG B 150 N LEU B 124

LINK C TYR B 159 N TPO B 160 1555 1555 1.33 LINK C TPO B 160 N HIS B 161 1555 1555 1.33 LINK MG MG B 383 OD1 ASN B 132 1555 1555 2.71 LINK MG MG B 383 O3B ATP B 381 1555 1555 2.99 LINK MG MG B 383 O2A ATP B 381 1555 1555 2.58 LINK MG MG B 383 O2G ATP B 381 1555 1555 2.61 LINK MG MG B 383 ND2 ASN B 132 1555 1555 2.58 LINK MG MG B 383 O1G ATP B 381 1555 1555 2.48

SITE 1 AC1 3 ASN B 132 ASP B 145 ATP B 381 SITE 1 AC2 17 ILE B 10 GLY B 13 THR B 14 VAL B 18 SITE 2 AC2 17 ALA B 31 LYS B 33 GLU B 81 PHE B 82 SITE 3 AC2 17 LEU B 83 ASP B 86 LYS B 89 ASP B 127 SITE 4 AC2 17 LYS B 129 GLN B 131 ASN B 132 ASP B 145 SITE 5 AC2 17 MG B 383

CRYST1 134.450 134.450 65.800 90.00 90.00 120.00 P 32 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.007438 0.004294 0.000000 0.00000

SCALE2 0.000000 0.008588 0.000000 0.00000

SCALE3 0.000000 0.000000 0.015198 0.00000